These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 17604654

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies.
    Steinhoff BJ, Ben-Menachem E, Ryvlin P, Shorvon S, Kramer L, Satlin A, Squillacote D, Yang H, Zhu J, Laurenza A.
    Epilepsia; 2013 Aug; 54(8):1481-9. PubMed ID: 23663001
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Pregabalin: as adjunctive treatment of partial seizures.
    Warner G, Figgitt DP.
    CNS Drugs; 2005 Aug; 19(3):265-72; discussion 273-4. PubMed ID: 15740180
    [Abstract] [Full Text] [Related]

  • 66. Increasing the dosage of pregabalin in patients with focal epilepsy decreases the frequency of seizures and ameliorates symptoms of anxiety, depression and insomnia.
    Murawiec S, Chudek J, Nieves W, Almgren-Rachtan A, Jedrzejczak J.
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13015-13024. PubMed ID: 33378053
    [Abstract] [Full Text] [Related]

  • 67. Double-blind, placebo-controlled, cross-over trial of progabide as add-on therapy in epileptic patients.
    de Pasquet EG, Scaramelli A, de Cáceres MP, L'Héritier C, Feldman S, Santana R, Aguilar J, Musch B, Morselli PL.
    Epilepsia; 1991 Dec; 32(1):133-9. PubMed ID: 1985823
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. Immediate and controlled-release pregabalin for the treatment of epilepsy.
    Morano A, Palleria C, Citraro R, Nesci V, De Caro C, Giallonardo AT, De Sarro G, Russo E, Di Bonaventura C.
    Expert Rev Neurother; 2019 Dec; 19(12):1167-1177. PubMed ID: 31623493
    [Abstract] [Full Text] [Related]

  • 72. Movement disorders associated with antiseizure medications: A systematic review.
    Zhou DJ, Pavuluri S, Snehal I, Schmidt CM, Situ-Kcomt M, Taraschenko O.
    Epilepsy Behav; 2022 Jun; 131(Pt A):108693. PubMed ID: 35483204
    [Abstract] [Full Text] [Related]

  • 73. Variability in expression of the human MDR1 drug efflux transporter and genetic variation of the ABCB1 gene: implications for drug-resistant epilepsy.
    Heinrich A, Zhong XB, Rasmussen TP.
    Curr Opin Toxicol; 2018 Jun; 11-12():35-42. PubMed ID: 31602418
    [Abstract] [Full Text] [Related]

  • 74. Efficacy of pregabalin in childhood refractory partial seizure.
    Zamani G, Tavasoli A, Zare-Shahabadi A, Rezaei N, Ahmadvand A.
    Iran J Pediatr; 2014 Feb; 24(1):100-4. PubMed ID: 25793053
    [Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. The safety and tolerability of newer antiepileptic drugs in children and adolescents.
    Sarco DP, Bourgeois BF.
    CNS Drugs; 2010 May; 24(5):399-430. PubMed ID: 20192278
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. Pregabalin as adjunctive therapy for partial epilepsy: an audit study in 96 patients from the South East of England.
    Valentin A, Moran N, Hadden R, Oakes A, Elwes R, Delamont R, Mullatti N, Nashef L.
    Seizure; 2009 Jul; 18(6):450-2. PubMed ID: 19213577
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.